Scholar Rock shares jump 300% after rare disease drug scores trial …
Oct 7, 2024 · Scholar Rock is expected to report data from the obesity studies in the second quarter of 2025. Its shares were trading at $30.38. Until Friday's close of $7.42, the stock had …
OFF
Scholar Rock Shares Jump 300% After Rare Disease Drug Scores Trial …
3 weeks from now
Oct 7, 2024 · Scholar Rock is expected to report data from the obesity studies in the second quarter of 2025. Its shares were trading at $30.38. Until Friday's close of $7.42, the stock had …
reuters.com
OFF
Scholar Rock Scores $300M For Regulatory Filings & Launch Plans …
3 weeks from now
Oct 9, 2024 · Shares of Scholar Rock soared more than 300% after the biotech’s data release, and the company seized on the opportunity to raise money. Late Tuesday, Scholar Rock …
medcitynews.com
OFF
Scholar Rock Shares Soar 320% On Positive SMA Trial Results
3 weeks from now
Jan 24, 2025 · Scholar Rock Shares Soar 320% on Positive SMA Trial Results. By Eric Blancaro ... This strategic move signals confidence in the drug’s potential and the company’s …
thefinancialanalyst.net
OFF
Scholar Rock Stocks Skyrocket After SMA Drug Scores At Phase III
3 weeks from now
The company’s stock price rocketed by 362% after the news dropped, from a 4 October close of $7.42 to a close of $34.28 yesterday (7 October).
yahoo.com
OFF
Scholar Rock Scores $300M For Regulatory Filings & Launch Plans …
3 weeks from now
Oct 10, 2024 · Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After …
health-reporter.news
OFF
Scholar Rock Shares Jump 300% After Rare Disease Drug Scores Trial …
3 weeks from now
Oct 7, 2024 · Scholar Rock's SRRK experimental drug achieved its main target in a late-stage trial for spinal muscular atrophy, the biotech company said on Monday, sending its shares soaring …
tradingview.com
OFF
Scholar Rock Ignites Retail Buzz As Stock Rockets 300% On
3 weeks from now
Oct 7, 2024 · As of 11 a.m. ET, Scholar Rock was the top gainer on U.S. exchanges, with trading volume at 25 million shares, nearly 30 times its daily average. Spinal muscular atrophy is a …
stocktwits.com
OFF
SRRK Stock Soars As Muscle Disease Drug Meets Phase III Study Goal
3 weeks from now
Oct 8, 2024 · Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and …
nasdaq.com
OFF
Scholar Rock Holding (SRRK) Stock Rockets Up On Positive Phase 3 …
3 weeks from now
Oct 9, 2024 · Scholar Rock Holding (SRRK) has shown a staggering 335% jump in share price following the success of its spinal muscular atrophy (SMA) treatment drug, Apitegromab, in a …
nasdaq.com
OFF
Scholar Rock Shares Target Increased, Holds Buy On SMA Drug …
3 weeks from now
Nov 25, 2024 · Monday, Truist Securities adjusted its outlook on Scholar Rock (NASDAQ:SRRK) shares, raising the biotechnology company's price target from $36.00 to $45.00 while …
investing.com
OFF
Scholar Rock Surges As Genetic Disease Drug Succeeds In Late …
3 weeks from now
Oct 7, 2024 · ** Shares of Scholar Rock SRRK more than triple in value to $24.24 premarket ** Says its drug, apitegromab, met the main goal in a late-stage trial in patients with a type of …
tradingview.com
FAQs about Scholar Rock shares jump 300% after rare disease drug scores trial … Coupon?
Did scholar rock achieve its main target in a late-stage trial?
Is scholar rock a good SMA drug?
Why did scholar rock raise $300 million?
Why did Scholar Rock stock rise 200% on Monday?
Will scholar rock get FDA approval in the first quarter?
Is scholar rock a good Biotech stock to buy?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
